Abstract:Objective:To study 99m Tc labeled anti CEA antibody C50 fragment Fab’ and its biodistribution. Methods: F(ab)’ 2 of C50 was reduced by 2 mercapthonal and purified by Sephadex G50 column. Fab’ was obtained with a purity of over 90%. 0.6 1.0 mg Fab’(1.0 ml) was mixed with 0.4 0.8 mg glucoheptonate, followed by adding 5 10 μl freshly prepared SnCl 2 solution (1.0 mg SnCl 2 in 0.01 mol·L -1 HCl). Then about 1.0 ml of freshly eluted Na 99m TcO 4 was added to the mixture mentioned above and the mixture was slightly shaken. The solution was incubated at room temperature for 15 min. The labeling efficiency was determined by HPLC or ITLC SG method.Nude mice bearing CL 187 tumor xenografts were injected with 99m Tc Fab’ via vein tail and the ID(%)/g (% injected doses /g) of organs were obtained at various time points of postinjection. Results: The labeling efficiency of 99m Tc Fab’ was more than 90%. The ratios of tumor to blood, liver and lung were 1.93, 2.35 and 3.13 4 hours after injection. In addition, these ratios reached up to 4.91, 2.62, and 5.26, 24 hours after injection respectively. 4 hours and 24 hours after injection of 99m Tc Fab’, the ID(%)/g of tumor was 4.53 and 2.73 respectively. Although at the 24 th hour, the ID(%)/g of tumor of 99m Tc C50(intact) reached up to 12.5, the ratio of tumor/blood was only about 1.5. Conclusion: 99m Tc labeled Fab' was successfully prepared by direct labeling technique, and the T/NT ratios were more than 2.0 except that with the kidney which was significantly higher than that of 99m Tc labeled C50 (intact). These are favorable to get clear images at earlier time after injection of 99m Tc Fab'. These indicate that 99m Tc C50 Fab' seems to be a good radiopharmaceutical for RII.

Experimental Study of the Biological Property and Safety Limitation of 99Mtc-C50

Studies of 99mTc labeled carcinoembyronic antigen monoclonal antibody C50 fragment Fab' and biodistrobution

Experimental Study of Biological Property and Safety Limitation of Sentinel Lymph Node Imaging Agent 99Tcm-Rituximab

Radiolabeling and preclinical evaluation of technetium-99m labeled colistin

Technetium-99m Labeling on Monoclonal Antibodies Via N,N'-Ethylene-Bis-L-Cysteine

Preparation and Preliminary Biological Evaluation of 99Mtc-Anmdu

Radiolabelling and Biological Evaluation of ~(99)Tc~m-mAb109 Against Breast Cancer

Synthesis and biodistribution of 99Tcm-Cetuximab antibody for lung tumor targeted molecular imaging

Radioimmunoimaging and Biodistribution of ~(131)I Labeled Anti-Cea Monoclonal Antibody C50 in Nude Mice Bearing Human Breast Carcinoma Xenografts

Initial Evaluation of 99m Tc-labeled Anti-Carcinoembryonic Antigen Single-Chain Fragment Variable for Micro-Single-photon Emission Computed Tomography Imaging in Mice with Colorectal Cancer.

Initial evaluation of 99m Tc‐labeled anti‐CEA scFv for micro‐SPECT imaging in mice with colorectal cancer

Synthesis and Preliminary Biological Evaluation of a Technetium-99M Labeled Thymidine Analog

99Mtc-Labeled HAb18 McAb Fab Fragment for Radioimmunoimaging in Nude Mice Bearing Human Hepatocellular Carcinoma.

Development and evaluation of a radiolabelling agent for white blood cell scans

Direct radio-labeling of 99Tcm-IgG and its biologic distribution study

The Biodistribution and Pretargeting Radioimmunoimaging of the Fusion Protein of Anti-Cea Single-Chain Antibody and Core-Streptavidin in Human Rectocolonic Tumor Bearing Nude Mice

Characterization of Monoclonal Antibody CL58 Against Carcinoembryonic Antigen (CEA) and Study of Its Biodistribution

Study on pharmacokinetics and acute toxicity of new molecular probe 99 m Tc-RRL

99mTc(I)‐Labeled His‐Tagged Proteins: Impact in the Development of Novel Imaging Probes and in Drug Discovery

Transplanted Murine Tumours SPECT Imaging with 99mTc Delivered with an Artificial Recombinant Protein

Radioactive Imagine Agents: 99mTc-Toxicological Study